Non-debatable issues in defining blood pressure targets for hypertension – Editorial
Saved in:
| Main Authors: | Brent M. Egan, Sverre E. Kjeldsen, Krzysztof Narkiewicz, Reinhold Kreutz, Michel Burnier, Giuseppe Mancia |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Blood Pressure |
| Online Access: | https://www.tandfonline.com/doi/10.1080/08037051.2025.2544721 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Should treatment of ‘elevated’ blood pressure, especially in older people, be based on global risk estimation?
by: Sverre E. Kjeldsen, et al.
Published: (2024-12-01) -
Lowering of systolic blood pressure in hypertensive patients: insights and questions from the ESPRIT study
by: Reinhold Kreutz, et al.
Published: (2024-12-01) -
Management of ‘Elevated’ blood pressure according to the 2024 European Society of Cardiology Guidelines: lack of supportive evidence and high risk of excessive treatment
by: Sverre E. Kjeldsen, et al.
Published: (2025-12-01) -
In memoriam: Stevo Julius, MD, ScD
by: Sverre E. Kjeldsen, et al.
Published: (2025-12-01) -
Clarifying the definition of ‘elevated’ blood pressure in the 2024 European Society of Cardiology hypertension guidelines
by: Giuseppe Mancia, et al.
Published: (2025-12-01)